Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
TEESUVAC ApS
APS
Active
CVR 35206701
Agern Alle 5A, 2970
Hørsholm
Manufacture of irradiation, electromedical and electrotherapeutic equipment
·
NACE 2660
Est. 2013 · 13 years old
7 employees
www.teesuvac.com
Monitor
Share
Denmark
/
Companies
/
Manufacture of irradiation, electromedical and electrotherapeutic equipment
/
TEESUVAC ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
10M
5M
0M
-4M
-9M
2021: -5M
-5M
2021
2022: -3M (+40% vs 2021)
-3M
+40%
2022
2023: -2M (+33% vs 2022)
-2M
+33%
2023
2024: -3M (-50% vs 2023)
-3M
-50%
2024
2025: 6M (+300% vs 2024)
6M
+300%
2025
EBITDA
DKK millions
0M
-3M
-6M
-9M
-12M
2021: -9M
-9M
2021
2022: -8M (+11% vs 2021)
-8M
+11%
2022
2023: -7M (+13% vs 2022)
-7M
+13%
2023
2024: -10M (-43% vs 2023)
-10M
-43%
2024
2025: 0M (+100% vs 2024)
0M
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
5.830
-2.954
-1.934
-3.323
-4.713
Staff expenses
-5.789
-6.790
-5.064
-4.655
-4.473
EBITDA
40
-9.744
-6.998
-7.978
-9.187
Depreciation & amort.
-10
-10
-10
-10
-17
EBIT
30
-9.754
-7.008
-7.988
-9.204
Net financials
-1.856
-2.882
-3.005
-1.781
-1.484
Profit before tax
-1.825
-12.636
-10.013
-9.769
-10.688
Tax
-193
-1.614
-1.105
-1.341
-1.640
Net profit
-1.633
-11.022
-8.908
-8.428
-9.048
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
6.006
5.438
2.527
4.359
7.522
Equity
-39.020
-37.387
-26.365
-17.457
-9.029
Long-term debt
16.758
15.937
4.792
16.038
15.750
Short-term debt
28.268
26.888
24.099
5.778
801
Total debt
45.026
42.825
28.892
21.816
16.551
Financial ratios
5-year trend
EBITDA margin (of gross profit)
0,7 %
This company
2021
2025
Equity ratio
-649,7 %
This company
38,2 %
Market median
This company
Market median
>999% below market
2021
2025
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2021
2025
Net profit margin (of gross profit)
-28,0 %
This company
2021
2025
Asset turnover (of gross profit)
0,97×
This company
2021
2025
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on TEESUVAC ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
